ArticleMultiple sclerosis and related disorders2023

Targeting miR-223 enhances myeloid-derived suppressor cell suppressive activities in multiple sclerosis patients.

Claudia Cantoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.